First hurdles cleared with the FDA. Already approved in Europe, only a matter of time until US sales take off once they receive final clearance. At ~$90,000 a pop for the LVAD (bridge device for helping hearts pump blood until a new heart if found for patients).
Zacks Top Ten Stocks for 2011 are now available! This 10-stock portfolio is a well-balanced mix of aggressive and conservative, large and small cap, growth and value. Buy them. Hold them. Watch your gains add up
Ride Momentum Stocks to Quick Gains!
The market is finally breaking out, creating the perfectd wave for investing in momentum stocks. Zacks is the king of fundamental analysis, but this service also uses technical indicators for the best possible timing. Click here to learn more >>.